Bacteriophages as potential new mammalian pathogens

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Tetz, George V ^a   Ruggles, Kelly V ^b,c   Zhou, Hua ^c   Heguy, Adriana ^b   Tsirigos, Aristotelis ^b,c   Tetz, Victor ^a  

^a Institute of Human Microbiology   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; LACTULOSE; MANNITOL;

ANIMAL; BACTERIAL TRANSLOCATION; BACTERIOPHAGE; BLOOD; BLOOD ANALYSIS; DISEASE MODEL; GASTROINTESTINAL TRACT; INTESTINE FLORA; MICROBIOLOGY; PATHOGENICITY; RAT;

ANIMALS; BACTERIAL TRANSLOCATION; BACTERIOPHAGES; BLOOD CHEMICAL ANALYSIS; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTOXINS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; LACTULOSE; MANNITOL; RATS;

EID: 85026753488     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-07278-6     Document Type: Article

References (61)

1. Natividad, J. & Verdu, E. Modulation of intestinal barrier by intestinal microbiota: Pathological and therapeutic implications. Pharmacol. Res. 69, 42-51 (2013).
2. Sommer, F. & Bäckhed, F. The gut microbiota-masters of host development and physiology. Nat. Rev. Microbiol. 11, 227-238 (2013).
3. Ashida, H., Ogawa, M., Kim, M., Mimuro, H. & Sasakawa, C. Bacteria and host interactions in the gut epithelial barrier. Nature Chemical Biology 8, 36-45 (2011).
4. König, J. et al. Human Intestinal Barrier Function in Health and Disease. Clin. Transl. Gastroenterol. 7, e196 (2016).
5. Rhee, S., Pothoulakis, C. & Mayer, E. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat. Rev. Gastroenterol. Hepatol. 6, 306-314 (2009).
6. Vaarala, O., Atkinson, M. & Neu, J. The "Perfect Storm" for Type 1 Diabetes: The Complex Interplay Between Intestinal Microbiota, Gut Permeability, and Mucosal Immunity. Diabetes 57, 2555-2562 (2008).
7. Bischoff, S. et al. Intestinal permeability-a new target for disease prevention and therapy. BMC Gastroenterol. 14 (2014).
8. Kaliannan, K., Wang, B., Li, X., Kim, K. & Kang, J. A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia. Sci. Rep. 5, 11276 (2015).
9. van Vliet, M., Harmsen, H., de Bont, E. & Tissing, W. The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis. PLoS Pathog. 6, e1000879 (2010).
10. Dalmasso, M., Hill, C. & Ross, R. Exploiting gut bacteriophages for human health. Trends Microbiol. 22, 399-405 (2014).
11. Mills, S. et al. Movers and shakers. Gut Microbes 4, 4-16 (2013).
12. Sulakvelidze, A., Alavidze, Z. & Morris, J. Bacteriophage Therapy. Antimicrob. Agents Chemother. 45, 649-659 (2001).
13. Wittebole, X., De Roock, S. & Opal, S. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence 5, 226-235 (2013).
14. Tetz, G. & Tetz, V. Bacteriophage infections of microbiota can lead to leaky gut in an experimental rodent model. Gut Pathog. 8 (2016).
15. Claesson, M. et al. Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions. Nucleic Acids Res. 38, e200-e200 (2010).
16. Nemzek, J. A., Hugunin, K. & Opp, M. R. Modeling sepsis in the laboratory: merging sound science with animal well-being. Comp. med. 58, 120-128 (2008).
17. Wang, L. et al. Methods to determine intestinal permeability and bacterial translocation during liver disease. J. Immunol. Methods 421, 44-53 (2015).
18. Ding, L. Effects of glutamine on intestinal permeability and bacterial translocation in TPN-rats with endotoxemia. World J. Gastroenterol. 9, 1327 (2003).
19. Fukui, H. Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia. World J. Hepatol. 7, 425-442 (2015).
20. Yu, C. et al. Chronic Kidney Disease Induced Intestinal Mucosal Barrier Damage Associated with Intestinal Oxidative Stress Injury. Gastroenterol Res. Pract. 2016, 1-9 (2016).
21. D'Argenio, G. et al. Symbiotic formulation in experimentally induced liver fibrosis in rats: intestinal microbiota as a key point to treat liver damage Liver Int. 33, 687-697 (2013).
22. Schloss, P. et al. Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities. Appl. Environ. Microbiol. 75, 7537-7541 (2009).
23. Dethlefsen, L., Huse, S., Sogin, M. & Relman, D. The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing. PLoS Biol. 6, e280 (2008).
24. Odenwald, M. & Turner, J. Intestinal Permeability Defects: Is It Time to Treat Clin. Gastroenterol. Hepatol. 11, 1075-1083 (2013).
25. Tremaroli, V. & Bäckhed, F. Functional interactions between the gut microbiota and host metabolism. Nature 489, 242-249 (2012).
26. De Paepe, M., Leclerc, M., Tinsley, C. R. & Petit, M. A. Bacteriophages: An underestimated role in human and animal health Front Cell Infect Microbiol. 4, 39 (2014).
27. Duerkop, B. A. & Hooper, L. V. Resident viruses and their interactions with the immune system. Nat. immunol. 14, 654-659 (2013).
28. Fischetti, V. Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol. 13, 491-496 (2005).
29. Collins, S., Denou, E., Verdu, E. & Bercik, P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig. Liver Dis. 41, 850-853 (2009).
30. Maes, M., Kubera, M., Leunis, J. & Berk, M. Increased IgA and IgM responses against gut commensals in chronic depression: Further evidence for increased bacterial translocation or leaky gut. J. Affect. Dis. 141, 55-62 (2012).
31. Costello, M. et al. Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis. Arthritis Rheum 67, 686-691 (2015).
32. McLean, M., Dieguez, D., Miller, L. & Young, H. Does the microbiota play a role in the pathogenesis of autoimmune diseases Gut 64, 332-341 (2014).
33. Dabrowska, K., Switala-Jelen, K., Opolski, A., Weber-Dabrowska, B. & Gorski, A. Bacteriophage penetration in vertebrates. J. Appl. Microbiol. 98, 7-13 (2005).
34. Kutter, E. et al. Phage Therapy in Clinical Practice: Treatment of Human Infections. Curr. Pharm. Biotechnol. 11, 69-86 (2010).
35. Laval, L. et al. Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice. Gut Microbes 6, 1-9 (2015).
36. Mennigen, R. & Bruewer, M. Effect of Probiotics on Intestinal Barrier Function. Ann. N. Y. Acad. Sci. 1165, 183-189 (2009).
37. Martín, R. et al. Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiol. 15 (2015).
38. Singh, N. et al. Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis. Immunity 40, 128-139 (2014).
39. Lewis, K. et al. Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm. Bowel Dis. 16, 1138-1148 (2010).
40. Burger-van Paassen, N. et al. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochem. J. 420, 211-219 (2009).
41. Blaser, M. & Kirschner, D. The equilibria that allow bacterial persistence in human hosts. Nature 449, 843-849 (2007).
42. Kuramitsu, H. K., He, X., Lux, R., Anderson, M. H. & Shi, W. Interspecies interactions within oral microbial communities. Microbiol. Mol. Biol. Rev. 71, 653-670 (2007).
43. Filoche, S. K., Anderson, S. A. & Sissons, C. H. Biofilm growth of Lactobacillus species is promoted by Actinomyces species and Streptococcus mutans. Oral microbiology and immunology 19(5), 322-326 (2004).
44. Cao, L. & Yu, J. Effect of Helicobacter pylori infection on the composition of gastric microbiota in the development of gastric cancer. Gastrointest. Tumors 2, 14-25 (2015).
45. Servin, A. L. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS microbiol rev 28, 405-440 (2004).
46. López-Brea, M., Alarcón, T., Domingo, D. & Díaz-Regañón, J. Inhibitory effect of Gram-negative and Gram-positive microorganisms against Helicobacter pylori clinical isolates. J. Antimicrob. chemother. 61, 139-142 (2008).
47. Albus, U. Guide for the Care and Use of Laboratory Animals (8th edn) by the National Research Council of the National Academies Washington, DC: National Academies Press, 2011. Lab. Anim. 46, 267-268 (2012).
48. Bourdin, G. et al. Coverage of diarrhoea-associated Escherichia coli isolates from different origins with two types of phage cocktails. Microb. Biotechnol. 7, 165-176 (2014).
49. Meddings, J. & Swain, M. Environmental stress-induced gastrointestinal permeability is mediated by endogenous glucocorticoids in the rat. Gastroenterology 119, 1019-1028 (2000).
50. Parlesak, A., Schäfer, C., Schütz, T., Bode, J. & Bode, C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J. Hepatol. 32, 742-747 (2000).
51. Tsuji, E. et al. Simultaneous onset of acute inflammatory response, sepsislike symptoms and intestinal mucosal injury after cancer chemotherapy. Int. J. Cancer. 107, 303-308 (2003).
52. Amplicon, P. C. R., Clean-Up, P. C. R. & Index, P. C. R. 16S Metagenomic Sequencing Library Preparation. https://www. illumina. com/content/dam/illumina-support/documents/documentation/chemistry-documentation/16s/16s-metagenomic-library-prepguide-15044223-b. pdf (2013).
53. Bolger, A., Lohse, M. & Usadel, B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114-2120 (2014).
54. Edgar, R. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460-2461 (2010).
55. Zhang, Y., Wang, X., Hu, M. & Li, P. Effect of hydraulic retention time (HRT) on the biodegradation of trichloroethylene wastewater and anaerobic bacterial community in the UASB reactor. Appl. Microbiol. Biotechnol. 99, 1977-1987 (2014).
56. Wang, Q., Garrity, G., Tiedje, J. & Cole, J. Naive Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy. Appl Environ. Microbiol. 73, 5261-5267 (2007).
57. Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590-D596 (2012).
58. Caporaso, J. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335-336 (2010).
59. Cox, L. et al. Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences. Cell 158, 705-721 (2014).
60. Love, M., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq. 2. Genome Biology 15 (2014).
61. McMurdie, P. J. & Holmes, S. phyloseq: An R Package For Reproducible Interactive Analysis And Graphics Of Microbiome Census Data. PloS one 8, e61217 (2013).